RVMD Revolution Medicines edges higher after reporting wider than expected Q4 2025 per share loss XPEV XPeng Inc tops Q4 2025 EPS estimates by wide margin shares climb nearly 5 percent on upbeat investor reaction ONFOW Onfolio withholds formal quarterly earnings metrics set to share operational updates at its upcoming investor briefing